Published on 14 Feb 2023 on Simply Wall St. via Yahoo Finance
Whilst it may not be a huge deal, we thought it was good to see that the Vera Therapeutics, Inc. (NASDAQ:VERA) Chief Financial Officer, Sean Grant, recently bought US$100k worth of stock, for US$7.00 per share. Even though that isn't a massive buy, it did increase their holding by 207%, which is arguably a good sign.
Check out our latest analysis for Vera Therapeutics
Vera Therapeutics Insider Transactions Over The Last Year